Given our promising results demonstrating uptake of RNA via liposomes in a mouse PDX model, we sought to explore whether systemic administration of MTL-CEBPA could upregulate CEBPA expression in human leukemia cells engrafted in the bone marrow and spleen of mice. This evidence concerns the gene CEBPA and leukemia.